Daria V. Abbasova

Daria V. Abbasova

Auto-generated profile, based on publicly available information

Daria V. Abbasova

Sechenov First Moscow State Medical University (Sechenovskiy University)

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 June 2019 in Cancer Urology
Verified
Journal Article
Open access
PDF file
DAD. V. Abbasova
D. V. Abbasova
SPS. B. Polikarpova
S. B. Polikarpova
NKN. A. Kozlov
N. A. Kozlov
AMA. S. Markova
A. S. Markova
TBTatiana Bogush
Tatiana Bogush
VKV. Yu. Kirsanov
V. Yu. Kirsanov
Most often, neuroendocrine carcinoma (NEC) is found in the gastrointestinal tract, broncho-pulmonary system, but they can also occur in other organs, such as the kidney, bladder, which is of most interest because of the rarity of this pathology. Until recently, there was not even a proper morphological classification for kidney NEC, and among some histological types, such as large cell neuroendocrine carcinoma of the kidney, only about 7 cases were recorded, and independent bladder carcinoids, about 15 cases. Currently, there are no clinical and morphological features of the NEC of the kidney and bladder, fundamentally distinguishing them from other neuroendocrine tumors and “classic” cancer of the same localization. This article also provides the data of the N.N. Blokhin National Medical Research Centre of Oncology on the incidence of all malignant neoplasms of the urinary system.

15 September 2019 in Journal of Modern Oncology
Verified
Journal Article
Open access
DADaria V Abbasova
Daria V Abbasova
SPSvetlana B Polikarpova
Svetlana B Polikarpova
NKNikolai A Kozlov
Nikolai A Kozlov
MBMadina P Baranova
Madina P Baranova
IKIrina P Kovalenko
Irina P Kovalenko
ИИИгнатова Елена Игоревна
Игнатова Елена Игоревна
Neuroendocrine neoplasia (NEC) of the prostate gland is a rather rare extrapulmonary neuroendocrine carcinoma and makes up only 0.5 to 1% of all malignant neoplasms of this localization. NEC of the prostate gland is a tumor of epithelial origin, histologically and immunohistochemically identical to analogues in the lungs and digestive system. When stained with hemotoxylin-eosin, neuroendocrine cells cannot always be visualized; they are best recognized by the immunohistochemical method of investigation using specific markers. Currently, a number of neuroendocrine markers are used, the expression of which may indicate a neuroendocrine nature. Androgen neuroendocrine cells themselves are independent and do not cause an increase in the concentration of prostate-specific antigen. Prostate NECs are represented by some histological forms according to WHO classification (2015): 1. Adenocarcinoma with focal neuroendocrine differentiation. 2. Well-differentiated neuroendocrine tumor. 3. Small cell neuroendocrine cancer is a high - grade tumor with high malignant potential. 4. Large cell neuroendocrine cancer is a high - grade tumor. Due to the rarity of NEC of the prostate, a specific algorithm for diagnosis and treatment has not been developed, as a rule, they are similar to methods of other malignant forms of prostate cancer and neuroendocrine tumors.

5 December 2025 in Journal of Modern Oncology
Verified
Journal Article
Open access
PDF file
SWShuowen Wang
Shuowen Wang
MBMadina P. Baranova
Madina P. Baranova
DADaria V. Abbasova
Daria V. Abbasova
KXKONG XIANGYI
KONG XIANGYI
ZWZhongzhao Wang
Zhongzhao Wang
ХВХоробрых Татьяна Витальевна
Хоробрых Татьяна Витальевна
Introduction. Autologous adipose tissue transplantation (AATT) with platelet-rich plasma (PRP) is widely used in reconstructive and aesthetic breast surgery. However, differences in the methods of preparation of PRP and AATT, as well as in the approaches to the management of patients with breast cancer and without malignancies, require a comparative analysis to optimize clinical outcomes. Aim. To compare the surgical techniques and the results of PRP-assisted AATT in reconstructive and aesthetic breast surgery in three medical institutions in Russia and China. Materials and methods. Data from 84 patients in three centers were retrospectively analyzed: the Ruili Medical Cosmetic Hospital (RMCH, China, n=36), the Southeastern Hospital at Xiamen University (SEH, China, n=22), and the University Clinical Hospital No. 4 of the Sechenov University (UCH No. 4, Russia, n=26). Parameters of anesthesia, methods of harvesting and preparing AAT and PRP, the ratio of components, injection technique, and postoperative management were compared. Esthetic outcomes, graft survival, and complications were assessed. Results. In RMCH and SEH (aesthetic breast surgery), the volume of injected AAT was 150–250 mL per breast. The breast circumference increased by 3.19-6.28 cm after 6–12 months; 86–89% of patients achieved satisfactory results after 1–2 procedures. In UCH No. 4 (reconstruction after breast cancer), the volume of injected AAT was 50–100 mL per breast. The thickness of the subcutaneous fat layer increased by 1.4 cm (at 6 months) and 1.1 cm (at 12 months). Ten patients achieved the result after one procedure, while 16 required 2–3 lipofilling procedures. No complications were reported, and the graft survival rate did not correlate with the AAT volume. Conclusion. PRP-assisted AATT is effective and safe for aesthetic and reconstructive breast surgery. In patients with malignancies, a smaller volume of AAT and repeated procedures can provide correction of cicatricial defects and improve psychosocial status. Further research is needed to standardize the techniques.